CKD-386 formulation 1

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

DyslipidemiasHypertensionType2 Diabetes Mellitus

Phase 1

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2019-04-01End: 2019-05-31Target: 30Updated: 2019-04-19

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers

Chong Kun Dang PharmaceuticalType2 Diabetes Mellitus

Start: 2020-02-01End: 2020-06-15Target: 30Updated: 2020-01-10